GlassScriptPhysician profile
Ashma S Davidson
NPI 1427311497
$32,290.58
in general payments reported to CMS, 2019-2025
31 companies · $28K in 2025
The $28K reported for 2025 was more than what 99% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $231 · 2021: $161 · 2022: $1,718 · 2023: $1,353 · 2024: $568 · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $27K · Food and Beverage: $2,558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $27,400.00 |
| Food and Beverage | $2,557.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $27,482.15 | 2022-2025 | |
| Grt US Holding, INC. | $856.56 | 2020-2022 | |
| Smith+Nephew, INC. | $619.32 | 2019-2025 | Stravix Pl, Grafix Pl, Grafix Xc |
| Horizon Therapeutics Plc | $597.77 | 2019-2023 | Krystexxa |
| Amgen INC. | $452.13 | 2024-2025 | Krystexxa |
| Averitas Pharma INC. | $394.94 | 2023-2024 | Qutenza |
| Paratek Pharmaceuticals, INC. | $371.14 | 2022-2025 | Nuzyra |
| Progenacare Global, LLC | $337.67 | 2023 | |
| Epsfl, LLC | $139.97 | 2023 | |
| Kerecis Limited | $132.44 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Nevro Corp. | $130.35 | 2022-2023 | Senza |
| Treace Medical Concepts, INC. | $122.21 | 2022 | |
| Bioventus LLC | $119.53 | 2022-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Abbvie INC. | $96.72 | 2023-2025 | Dalvance |
| Organogenesis INC. | $66.16 | 2021-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $53.62 | 2021-2023 | Entre Plus, Flexitouch Plus |
| Next Science LLC | $35.31 | 2023 | Blastx, Xperience, Surgx |
| Curonix LLC | $31.52 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biowound Solutions, INC. | $31.20 | 2025 | Bio-Connekt |
| Advanced Oxygen Therapy INC. | $26.79 | 2024 | Topical Oxygen Chamber For Extremities |
| Medtronic, INC. | $24.95 | 2025 | Inceptiv |
| Arthrosurface Incorporated | $24.18 | 2019 | |
| Ibsa Pharma INC. | $19.88 | 2021 | |
| Triad Life Sciences INC. | $18.44 | 2022 | |
| Dynasplint Systems INC. | $18.24 | 2025 | Dynasplint |
| Mimedx Group, INC. | $16.01 | 2025 | |
| Kci USA, INC. | $15.52 | 2020 | |
| Hartmann USA, INC. | $15.34 | 2024 | Zetuvit Plus 10x10 P10 |
| Osiris Therapeutics INC. | $14.08 | 2019 | |
| Merck Sharp & Dohme LLC | $13.46 | 2019 | |
| Zimmer Biomet Holdings, INC. | $12.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashma Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.